The role of gangliosides in brain development and the potential benefits of perinatal supplementation

Nutrition Research

Volumn 33, Issue 11, 2013, Pages 877-887

  Ryan, Jennifer M ^a   Rice, Gregory E ^a   Mitchell, Murray D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Brain development; Dietary supplementation; Gangliosides; Maternal dietary supplementation; Nutrition

Indexed keywords

CALCIUM; CERAMIDE; CHOLESTEROL; CHOLINE; DOCOSAHEXAENOIC ACID; FISH OIL; GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT1B; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SELENIUM; TRACE ELEMENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BODY WEIGHT; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN PROTECTION; BRAIN WEIGHT; BREAST MILK; CALCIUM HOMEOSTASIS; CELL INTERACTION; CEREBRAL PALSY; CEREBROVASCULAR ACCIDENT; CHILD DEVELOPMENT; COGNITIVE DEVELOPMENT; COLOSTRUM; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG ACTIVITY; DRUG MEGADOSE; DRUG SAFETY; FETUS DEVELOPMENT; FETUS MALFORMATION; FOLIC ACID DEFICIENCY; FOOD COMPOSITION; FOOD INTAKE; HUMAN; INTELLIGENCE QUOTIENT; IRON DEFICIENCY; LACTATION; LEARNING DISORDER; LIPID DEGRADATION; LIPOGENESIS; LOW DRUG DOSE; MACRONUTRIENT; MATERNAL NUTRITION; MEMORY DISORDER; NERVOUS SYSTEM INJURY; NONHUMAN; NUTRITIONAL STATUS; PARKINSON DISEASE; PERINATAL PERIOD; PERIPHERAL NEUROPATHY; PREECLAMPSIA; PREGNANCY OUTCOME; PRENATAL PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; RISK REDUCTION; SURVIVAL; SYNAPTIC TRANSMISSION; ZINC DEFICIENCY;

BRAIN DEVELOPMENT; CER; CERAMIDE; CML; COMPLEX MILK LIPIDS; DHA; DIETARY SUPPLEMENTATION; DOCOSAHEXAENOIC ACID; GAL; GALACTOSE; GANGLIOSIDES; GLU; GLUCOSE; GMDS; GRIFFITHS MENTAL DEVELOPMENT SCALE; MATERNAL DIETARY SUPPLEMENTATION; MORRIS WATER MAZE; MWM; N-ACETYLNEURAMINIC ACID; NEU5AC; NORT; NOVEL OBJECT RECOGNITION TASK; NUTRITION; SA; SIALIC ACID;

BRAIN; BREAST FEEDING; CHILD DEVELOPMENT; COGNITION; DIETARY SUPPLEMENTS; FEMALE; GANGLIOSIDES; HUMANS; INFANT; LACTATION; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MILK, HUMAN; NERVOUS SYSTEM DISEASES;

EID: 84886382263     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2013.07.021     Document Type: Review

References (112)

1. Georgieff M.K. Nutrition and the developing brain: nutrient priorities and measurement. Am J Clin Nutr 2007, 85:614S-620S.
2. Rosales F.J., Zeisel S.H. Perspectives from the symposium: the role of nutrition in infant and toddler brain and behavioral development. Nutr Neurosci 2008, 11:135-143.
3. Wainwright P.E., Colombo J. Nutrition and the development of cognitive functions: interpretation of behavioral studies in animals and human infants. Am J Clin Nutr 2006, 84:961-970.
4. Burton GJ, Jauniaux E, Charnock-Jones DS. The influence of the intrauterine environment on human placental development. Int J Dev Biol 54:303-312.
5. Lechtig A., Yarbrough C., Delgado H., Habicht J.P. Influence of maternal nutrition on birth weight. Am J Clin Nutr 1975, 28:1223-1233.
6. Thame M., Wilks R.J., McFarlane-Anderson N., Bennett F.I. Relationship between maternal nutritional status and infant's weight and body proportions at birth. Eur J Clin Nutr 1997, 51:134-138.
7. Luke B., Dickinson C., Petrie R.H. Intrauterine growth: correlations of maternal nutritional status and rate of gestational weight gain. Eur J Obstet Gynecol Reprod Biol 1981, 12:113-121.
8. Abu-Saad K., Fraser D. Maternal nutrition and birth outcomes. Epidemiol Rev 2010, 32:5-25.
9. Victora C.G., Adair L., Fall C., Hallal P.C. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 2008, 371:340-357.
10. van Abeelen A.F., Veenendaal M.V., Painter R.C., de Rooij S.R. Survival effects of prenatal famine exposure. Am J Clin Nutr 2012, 95:179-183.
11. Roseboom T.J., Painter R.C., van Abeelen A.F., Veenendaal M.V. Hungry in the womb: what are the consequences? Lessons from the Dutch famine. Maturitas 2011, 70:141-145.
12. Stein A.D., Pierik F.H., Verrips G.H., Susser E.S. Maternal exposure to the Dutch famine before conception and during pregnancy: quality of life and depressive symptoms in adult offspring. Epidemiology 2009, 20:909-915.
13. Susser E.S., Lin S.P. Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. Arch Gen Psychiatry 1992, 49:983-988.
14. Painter R.C., Roseboom T.J., Bleker O.P. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 2005, 20:345-352.
15. Ladipo O.A. Nutrition in pregnancy: mineral and vitamin supplements. Am J Clin Nutr 2000, 72:280S-290S.
16. Massaro A.N. Fetal brain development: the role of maternal nutrition, exposures and behaviors. J Pediatr Neurol 2006, 4:1-9.
17. Lenz W. A short history of thalidomide embryopathy. Teratology 1988, 38:203-215.
18. Mellin G.W., Katzenstein M. The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies. N Engl J Med 1962, 267:1238-1244. concl.
19. Allen L.H. Biological mechanisms that might underlie iron's effects on fetal growth and preterm birth. J Nutr 2001, 131:581S-589S.
20. Allen L.H. Iron-deficiency anemia increases risk of preterm delivery. Nutr Rev 1993, 51:49-52.
21. Jameson S. Zinc status in pregnancy: the effect of zinc therapy on perinatal mortality, prematurity, and placental ablation. Ann N Y Acad Sci 1993, 678:178-192.
22. Scholl T.O., Hediger M.L., Schall J.I., Fischer R.L. Low zinc intake during pregnancy: its association with preterm and very preterm delivery. Am J Epidemiol 1993, 137:1115-1124.
23. Bhatnagar S., Taneja S. Zinc and cognitive development. Br J Nutr 2001, 85(Suppl 2):S139-S145.
24. Blencowe H., Cousens S., Modell B., Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010, 39(Suppl 1):i110-i121.
25. Pitkin R.M. Folate and neural tube defects. Am J Clin Nutr 2007, 85:285S-288S.
26. Guvenc H., Karatas F., Guvenc M., Kunc S. Low levels of selenium in mothers and their newborns in pregnancies with a neural tube defect. Pediatrics 1995, 95:879-882.
27. Vanderlelie Selenium and preeclampsia: a global perspective. Pregnancy Hypertens 2011, 1:213-224.
28. McCann J.C., Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005, 82:281-295.
29. Wainwright Role of dietary polyunsaturated fatty acids in brain and cognitive function: perspective of a developmental psychobiologist. Nutr Neurosci 2005, 163-186.
30. Lauritzen L., Hansen H.S., Jorgensen M.H., Michaelsen K.F. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 2001, 40:1-94.
31. Guesnet P., Alessandri J.M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS)-implications for dietary recommendations. Biochimie 2011, 93:7-12.
32. Ando S. Gangliosides in the nervous system. Neurochem Int 1983, 5:507-537.
33. Svennerholm L. Chromatographic separation of human brain gangliosides. J Neurochem 1963, 10:613-623.
34. Huwiler A., Kolter T., Pfeilschifter J., Sandhoff K. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 2000, 1485:63-99.
35. Shayman J.A. Sphingolipids. Kidney Int 2000, 58:11-26.
36. Skaper S.D., Leon A., Toffano G. Ganglioside function in the development and repair of the nervous system. From basic science to clinical application. Mol Neurobiol 1989, 3:173-199.
37. Fishman P.H., Brady R.O. Biosynthesis and function of gangliosides. Science 1976, 194:906-915.
38. Basu S., Kaufman B., Roseman S. Enzymatic synthesis of ceramide-glucose and ceramide-lactose by glycosyltransferases from embryonic chicken brain. J Biol Chem 1968, 243:5802-5804.
39. Prokazova N.V., Samovilova N.N., Gracheva E.V., Golovanova N.K. Ganglioside GM3 and its biological functions. Biochemistry (Mosc) 2009, 74:235-249.
40. Kolter T. Ganglioside biochemistry. ISRN Biochem 2012, 2012.
41. Kolter T., Proia R.L., Sandhoff K. Combinatorial ganglioside biosynthesis. J Biol Chem 2002, 277:25859-25862.
42. Yu R.K., Nakatani Y., Yanagisawa M. The role of glycosphingolipid metabolism in the developing brain. J Lipid Res 2009, 50(Suppl.):S440-S445.
43. Brunetti-Pierri N., Scaglia F. GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol Genet Metab 2008, 94:391-396.
44. Otnaess A.B., Laegreid A., Ertresvag K. Inhibition of enterotoxin from Escherichia coli and Vibrio cholerae by gangliosides from human milk. Infect Immun 1983, 40:563-569.
45. Suzuki Y., Nakamura N., Fukuoka K., Shimada Y. Beta-galactosidase deficiency in juvenile and adult patients. Report of six Japanese cases and review of literature. Hum Genet 1977, 36:219-229.
46. Wu G., Xie X., Lu Z.H., Ledeen R.W. Cerebellar neurons lacking complex gangliosides degenerate in the presence of depolarizing levels of potassium. Proc Natl Acad Sci U S A 2001, 98:307-312.
47. Furukawa K., Ohmi Y., Ohkawa Y., Tokuda N. Regulatory mechanisms of nervous systems with glycosphingolipids. Neurochem Res 2011, 36:1578-1586.
48. Yu R.K., Tsai Y.T., Ariga T. Functional roles of gangliosides in neurodevelopment: an overview of recent advances. Neurochem Res 2012, 37:1230-1244.
49. Varki A., Gagneux P. Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci 2012, 1253:16-36.
50. Hanada K. Sphingolipids in infectious diseases. Jpn J Infect Dis 2005, 58:131-148.
51. McJarrow P., Schnell N., Jumpsen J., Clandinin T. Influence of dietary gangliosides on neonatal brain development. Nutr Rev 2009, 67:451-463.
52. Ledeen R.W. Ganglioside structures and distribution: are they localized at the nerve ending?. J Supramol Struct 1978, 8:1-17.
53. Ledeen R.W., Skrivanek J.A., Tirri L.J., Margolis R.K. Gangliosides of the neuron: localization and origin. Adv Exp Med Biol 1976, 71:83-103.
54. Rosner H. Developmental expression and possible roles of gangliosides in brain development. Prog Mol Subcell Biol 2003, 32:49-73.
55. Goldman J.E., Hirano M., Yu R.K., Seyfried T.N. GD3 ganglioside is a glycolipid characteristic of immature neuroectodermal cells. J Neuroimmunol 1984, 7:179-192.
56. Sbaschnig-Agler M., Dreyfus H., Norton W.T., Sensenbrenner M. Gangliosides of cultured astroglia. Brain Res 1988, 461:98-106.
57. Svennerholm L., Rynmark B.M., Vilbergsson G., Fredman P. Gangliosides in human fetal brain. J Neurochem 1991, 56:1763-1768.
58. Willinger M., Schachner M. GM1 ganglioside as a marker for neuronal differentiation in mouse cerebellum. Dev Biol 1980, 74:101-117.
59. Kracun I., Rosner H., Drnovsek V., Vukelic Z. Gangliosides in the human brain development and aging. Neurochem Int 1992, 20:421-431.
60. Svennerholm L., Bostrom K., Jungbjer B., Olsson L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J Neurochem 1994, 63:1802-1811.
61. Wang B., Brand-Miller J. The role and potential of sialic acid in human nutrition. Eur J Clin Nutr 2003, 57:1351-1369.
62. Ledeen R., Wu G.J. GM1 in the nuclear envelope regulates nuclear calcium through association with a nuclear sodium-calcium exchanger. J Neurochem. 2007, 103(Suppl 1):126-134.
63. Labasque M., Faivre-Sarrailh C. GPI-anchored proteins at the node of Ranvier. FEBS Lett 2010, 584:1787-1792.
64. Posse de Chaves E., Sipione S. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett 2010, 584:1748-1759.
65. Ledeen R.W., Yu R.K., Eng L.F. Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component. J Neurochem 1973, 21:829-839.
66. Mocchetti I. Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell Mol Life Sci 2005, 62:2283-2294.
67. Ohmi Y., Ohkawa Y., Yamauchi Y., Tajima O. Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues. Neurochem Res 2012, 37:1185-1191.
68. Wu G., Lu Z.H., Kulkarni N., Amin R. Mice lacking major brain gangliosides develop parkinsonism. Neurochem Res 2011, 36:1706-1714.
69. Cannella M.S., Acher A.J., Ledeen R.W. Stimulation of neurite outgrowth in vitro by a glycero-ganglioside. Int J Dev Neurosci 1988, 6:319-326.
70. Rybak S., Ginzburg I., Yavin E. Gangliosides stimulate neurite outgrowth and induce tubulin mRNA accumulation in neural cells. Biochem Biophys Res Commun 1983, 116:974-980.
71. Nakajima J., Tsuji S., Nagai Y. Bioactive gangliosides: analysis of functional structures of the tetrasialoganglioside GQ1b which promotes neurite outgrowth. Biochim Biophys Acta 1986, 876:65-71.
72. Dreyfus H., Ferret B., Harth S., Gorio A. Metabolism and function of gangliosides in developing neurons. J Neurosci Res 1984, 12:311-322.
73. Morgan B.L., Oppenheimer J., Winick M. Effects of essential fatty acid deficiency during late gestation on brain N-acetylneuraminic acid metabolism and behaviour in the progeny. Br J Nutr 1981, 46:223-230.
74. Agnati L.F., Fuxe K., Benfenati F., Battistini N. Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment. Neurosci Lett 1983, 40:293-297.
75. Silva R.H., Felicio L.F., Frussa-Filho R. Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice. Psychopharmacology 1999, 141:111-117.
76. Carine K., Schengrund C.L. Effects of exogenous GM1 and GD1a on S20Y neuroblastoma cells. J Neurosci Res 1984, 12:59-69.
77. Mei Z.T., Zheng J.Z. Effects of exogenous gangliosides on learning and memory in rats. Jpn J Physiol 1993, 43(Suppl 1):S295-S299.
78. Jung W.R., Kim H.G., Kim K.L. Ganglioside GQ1b improves spatial learning and memory of rats as measured by the Y-maze and the Morris water maze tests. Neurosci Lett 2008, 439:220-225.
79. Bharucha V.A., Wakade C.G., Mahadik S.P., Karpiak S.E. GM1 ganglioside treatment reduces functional deficits associated with cortical focal ischemia. Exp Neurol 1991, 114:136-139.
80. Ramirez J.J., Fass-Holmes B., Karpiak S.E., Harshbarger R. Enhanced recovery of learned alternation in ganglioside-treated rats after unilateral entorhinal lesions. Behav Brain Res 1991, 43:99-101.
81. Fong T.G., Neff N.H., Hadjiconstantinou M. GM1 ganglioside improves spatial learning and memory of aged rats. Behav Brain Res 1997, 85:203-211.
82. Popov N., Toffano G., Riechert U., Matthies H. Effects of intraventricularly applied gangliosides and N-acetylneuraminic acid on acquisition and retention performance of a brightness discrimination task in rats. Pharmacol Biochem Behav 1989, 34:209-212.
83. Xu X.-Z., Zhu T.-C. Effect of ganglioside in repairing the neurological function of children with cerebral palsy: analysis of the curative efficacy in 2230 cases. Chin J Clin Rehab 2005, 9:122-123.
84. Battistin L., Cesari A., Galligioni F., Marin G. Effects of GM1 ganglioside in cerebrovascular diseases: a double-blind trial in 40 cases. Eur Neurol 1985, 24:343-351.
85. Svennerholm L., Brane G., Karlsson I., Lekman A. Alzheimer disease-effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme. Dement Geriatr Cogn Disord 2002, 14:128-136.
86. Schneider J.S., Sendek S., Daskalakis C., Cambi F. GM1 ganglioside in Parkinson's disease: results of a five year open study. J Neurol Sci 2010, 292:45-51.
87. Horowitz S.H. Ganglioside therapy in diabetic neuropathy. Muscle Nerve 1986, 9:531-536.
88. Moore K.H. Variation in ganglioside content of bovine dairy products. J Food Composition Analysis 2000, 13:783-790.
89. Gasa S., Makita A. Characterization of gangliosides from equine kidney and spleen. J Biochem 1980, 88:1119-1128.
90. Saito M., Kitamura H., Sugiyama K. Liver gangliosides of various animals ranging from fish to mammalian species. Comp Biochem Physiol B Biochem Mol Biol 2001, 129:747-758.
91. Wang B., Miller J.B., McNeil Y., McVeagh P. Sialic acid concentration of brain gangliosides: variation among eight mammalian species. Comp Biochem Physiol A Mol Integr Physiol 1998, 119:435-439.
92. Ph P. Estimate of dietary ganglioside intake in a group of healthy Edmontonians based on selected foods. J Food Composition Analysis 2011, 24:1032-1037.
93. Rueda R., Sabatel J.L., Maldonado J., Molina-Font J.A. Addition of gangliosides to an adapted milk formula modifies levels of fecal Escherichia coli in preterm newborn infants. J Pediatr 1998, 133:90-94.
94. Wang B. Sialic acid is an essential nutrient for brain development and cognition. Annu Rev Nutr 2009, 29:177-222.
95. Rueda R. The role of dietary gangliosides on immunity and the prevention of infection. Br J Nutr 2007, 98(Suppl 1):S68-S73.
96. Kolter T. Ganglioside biochemistry. ISRN Biochem 2012, 2012:36.
97. Rueda R., Maldonado J., Narbona E., Gil A. Neonatal dietary gangliosides. Early Hum Dev 1998, 53(Suppl.):S135-S147.
98. Pan X.L., Izumi T. Chronological changes in the ganglioside composition of human milk during lactation. Early Hum Dev 1999, 55:1-8.
99. Pan X.L., Izumi T. Variation of the ganglioside compositions of human milk, cow's milk and infant formulas. Early Hum Dev 2000, 57:25-31.
100. Rueda R., Puente R., Hueso P., Maldonado J. New data on content and distribution of gangliosides in human milk. Biol Chem Hoppe Seyler 1995, 376:723-727.
101. Wang B., McVeagh P., Petocz P., Brand-Miller J. Brain ganglioside and glycoprotein sialic acid in breastfed compared with formula-fed infants. Am J Clin Nutr 2003, 78:1024-1029.
102. Fergusson D.M., Beautrais A.L., Silva P.A. Breast-feeding and cognitive development in the first seven years of life. Soc Sci Med 1982, 16:1705-1708.
103. Lucas A., Morley R., Cole T.J., Lister G. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992, 339:261-264.
104. Rodgers B. Feeding in infancy and later ability and attainment: a longitudinal study. Dev Med Child Neurol 1978, 20:421-426.
105. Horwood L.J., Fergusson D.M. Breastfeeding and later cognitive and academic outcomes. Pediatrics 1998, 101:E9.
106. Anderson J.W., Johnstone B.M., Remley D.T. Breast-feeding and cognitive development: a meta-analysis. Am J Clin Nutr 1999, 70:525-535.
107. Park E.J., Suh M., Ramanujam K., Steiner K. Diet-induced changes in membrane gangliosides in rat intestinal mucosa, plasma and brain. J Pediatr Gastroenterol Nutr 2005, 40:487-495.
108. Wainwright P.E., Lomanowska A.M., McCutcheon D., Park E.J. Postnatal dietary supplementation with either gangliosides or choline: effects on spatial short-term memory in artificially-reared rats. Nutr Neurosci 2007, 10:67-77.
109. Vickers M.H., Guan J., Gustavsson M., Krageloh C.U. Supplementation with a mixture of complex lipids derived from milk to growing rats results in improvements in parameters related to growth and cognition. Nutr Res 2009, 29:426-435.
110. Gustavsson M., Hodgkinson S.C., Fong B., Norris C. Maternal supplementation with a complex milk lipid mixture during pregnancy and lactation alters neonatal brain lipid composition but lacks effect on cognitive function in rats. Nutr Res 2010, 30:279-289.
111. Gurnida D.A., Rowan A.M., Idjradinata P., Muchtadi D. Association of complex lipids containing gangliosides with cognitive development of 6-month-old infants. Early Hum Dev 2012, 88:595-601.
112. Mitchell M.D., Henare K., Balakrishnan B., Lowe E. Transfer of gangliosides across the human placenta. Placenta 2012, 33:312-316.